XOMA Co. (NASDAQ:XOMAO) Short Interest Update

XOMA Co. (NASDAQ:XOMAO) was the recipient of a large drop in short interest during the month of April. As of April 30th, there was short interest totaling 290 shares, a drop of 89.8% from the April 15th total of 2,830 shares. Based on an average daily volume of 8,328 shares, the days-to-cover ratio is presently 0.0 days.

XOMA Stock Performance

Shares of NASDAQ XOMAO traded down $0.03 during midday trading on Monday, hitting $25.27. 2,790 shares of the company’s stock were exchanged, compared to its average volume of 3,979. XOMA has a twelve month low of $24.86 and a twelve month high of $26.40. The stock’s 50 day moving average price is $25.49 and its 200-day moving average price is $25.43.

XOMA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 15th. Shareholders of record on Thursday, April 2nd were given a dividend of $0.5234 per share. This represents a $2.09 dividend on an annualized basis and a dividend yield of 8.3%. The ex-dividend date was Thursday, April 2nd.

About XOMA

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.